Background An important feature of severe acute respiratory syndrome coronavirus 2
pathogenesis is COVID-19-associated coagulopathy, characterised by increased thrombotic and …

Thrombotic complications occur at high rates in hospitalized patients with COVID‐19, yet
the impact of intensive antithrombotic therapy on mortality is uncertain. We examined in‐…

Purpose: To test the feasibility, safety, immunogenicity, and clinical efficacy of an autologous
vaccine of leukocyte-derived heat shock protein 70-peptide complexes (Hsp70PC), in …

Central venous catheters are essential to the modern-day management of many illnesses
especially cancer and hematologic disorders. Catheter malfunction due to catheter tip …

Leukocytes provide a broad range of responses when dealing with foreign invaders, such
as bacterial organisms or tumor cells, including the formation of cell surface fibrin. The …

Background Heat shock protein 90 (HSP90) inhibitors have emerged as a promising class of
anti-cancer drugs in both solid and hematologic malignancies. The HSP90 family includes …

A retrospective study was done to determine the incidence of and the risk factors predisposing
to clinical venous thromboembolism (VTE) in patients treated for high grade gliomas. …

Objectives: To compare the complication rate (bleeding and thrombosis) of oral anticoagulation
in a cohort of patients with cancer to a cohort without cancer Design: Prospective cohort …

Fifty-one of 300 patients undergoing high-dose chemotherapy with (n = 245) or without (n =
55) autologous stem cell rescue developed central venous catheter-related thrombosis …

Bolus Infusion of clotting factor concentrates remains the most common approach to the
treatment or prevention of bleeding in patients with hemophilia. Although successful use of …